The efficacy of generic imatinib as first- and second-line therapy: three year follow-up of chronic myeloid leukemia patients
Islamagic, Erna, Ms, Hasic, Azra, MD, Kurtovic, Sabira, MD, Hadzimesic, Emina Suljovic, MD, Mehinovic, Lejla, Ms, Kozaric, Mirza, MD, Kurtovic-Kozaric, Amina, PhD
Published in Clinical lymphoma, myeloma and leukemia (2017)
Published in Clinical lymphoma, myeloma and leukemia (2017)
Get full text
Journal Article